DUPIXENT was studied in a 52-week trial with 106 adults with BP. Over the course of the trial, some patients on DUPIXENT
achieved sustained remission.*
(18% on DUPIXENT vs 6% on
placebo)
(38% on DUPIXENT vs 11% on
placebo)
(2.8 g for patients on DUPIXENT vs
4.1 g on placebo)
*That means there are no new blisters, old ones are healing, and steroids are tapered off by Week 16, with no relapses from Week 16 to Week 36, and no rescue treatment through Week 36.
†This analysis was not statistically significant.
The most common side effects in
patients with bullous pemphigoid
include:
joint pain (arthralgia), eye
problems, including eye and eyelid
inflammation,
redness, swelling,
itching, and blurred vision, and herpes
virus infections.
It is possible to manage your BP signs and symptoms. Take these next steps to get started on a treatment journey that may work for you.